Immunotherapy Drug Keytruda Approved For Colon Cancer Patients With Specific Tumor Abnormalities

Updated June 10th, 2021

Immunotherapy Drug Keytruda Approved For Colon Cancer Patients With Specific Tumor Abnormalities

A new option for the treatment of metastatic colorectal cancer, immune checkpoint inhibitor Keytruda, has been approved by the FDA -- marking historic progress for certain patients

NOW
PLAYING
FDA Approves Combination of Keytruda & Lenvima For Treatment Of Advanced Uterine Cancer: What Women Need To Know
NOW
PLAYING
'It's A Game Changer': FDA Approves Keytruda, Chemo Combo To Treat Aggressive Triple Negative Breast Cancer
NOW
PLAYING
Do You Have a Question About Mental Health & Cancer-- Ask Dr. Strongin-- A New Column From SurvivorNet
NOW
PLAYING
First Melanoma Patient Gets mRNA Cancer Vaccine From Medical Company That Cracked COVID; How Does mRNA Work?
NOW
PLAYING
4 Major Cancer Treatment Advances Happened This Week. Here's What You Missed.
NOW
PLAYING
Major Advance: PARP Inhibitors Extend Life For Women With High Risk Breast Cancer & BRCA Mutations

Treatment: Making Wise Surgery Decisions

SEE MORE   

Treatment: Making Wise Surgery Decisions

There is plenty of marketing information out there about the best surgery techniques, and the best places to have your operation done. Doing your own research is crucial before committing to any treatment.

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.